These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3566832)

  • 1. Potentiation of the locomotor activity of memantine by aminophylline.
    Youssif N; Ammon HP
    Arzneimittelforschung; 1986 Dec; 36(12):1717-20. PubMed ID: 3566832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacodynamics and pharmacokinetics of memantine].
    Wesemann W; Sontag KH; Maj J
    Arzneimittelforschung; 1983; 33(8):1122-34. PubMed ID: 6357202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Effect of memantine on spinal alpha-motoneurons and on the content of dopamine, noradrenaline and serotonin in the striatum and lumbar spinal cord].
    Sontag KH; Wand P; Schwarz M; Wesemann W; Osborne NN
    Arzneimittelforschung; 1982; 32(10):1236-40. PubMed ID: 6891222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of memantine on the anticonvulsant effects of the antiepileptic drugs.
    Chojnacka-Wójcik E; Tatarczyńska E; Maj J
    Pol J Pharmacol Pharm; 1983; 35(6):511-5. PubMed ID: 6429651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
    Fredriksson A; Archer T
    Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of memantine on central neurotransmitter systems. Review of the results].
    Maj J
    Arzneimittelforschung; 1982; 32(10):1256-9. PubMed ID: 6129854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of jumping behavior by aminophylline in mice treated with threshold doses of amphentamine and dopa.
    Colpaert FC; Lal H
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):587-90. PubMed ID: 4445575
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.
    Egashira N; Okuno R; Harada S; Matsushita M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 May; 586(1-3):164-70. PubMed ID: 18423440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats.
    Skuza G; Rogoz Z; Quack G; Danysz W
    J Neural Transm Gen Sect; 1994; 98(1):57-67. PubMed ID: 7710739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN; Ansseau M; Lemaire M; Abraini JH
    Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of memantine on various neurobiological processes.
    Osborne NN; Beale R; Golombiowska-Nikitin K; Sontag KH
    Arzneimittelforschung; 1982; 32(10):1246-55. PubMed ID: 6185123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of memantine (dimethylamino-adamantane) on membranes of sensory nerve fibres (author's transl)].
    Grossmann W; Jurna I
    Arzneimittelforschung; 1977 Jul; 27(7):1483-7. PubMed ID: 578479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evidence for the involvement of GABA-ergic system in the locomotor stimulation produced in mice by 1,3-dimethyl-5-aminoadamantane (D-145).
    Menon MK; Clark WG
    Neuropharmacology; 1978 Dec; 17(12):1049-52. PubMed ID: 745691
    [No Abstract]   [Full Text] [Related]  

  • 14. GABA-ergic drugs block the locomotor stimulant effects of 1,3-dimethyl-5-aminoadamantane (D-145).
    Menon MK; Clark WG
    Neuropharmacology; 1979 Feb; 18(2):223-5. PubMed ID: 431791
    [No Abstract]   [Full Text] [Related]  

  • 15. [Circadian rhythm of mortality, spontaneous locomotor activity, and LD50 following application of 1,1,2,2,-tetrabromoethane alone and in combination with ethanol].
    Wolff DL
    Acta Biol Med Ger; 1982; 41(10):945-52. PubMed ID: 7170866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease.
    Minkeviciene R; Banerjee P; Tanila H
    J Pharmacol Exp Ther; 2004 Nov; 311(2):677-82. PubMed ID: 15192085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine withdrawal syndrome in social interaction test in mice: effects of the NMDA receptor channel blockers, memantine and neramexane.
    Sukhotina IA; Zvartau EE; Danysz W; Bespalov AY
    Behav Pharmacol; 2004 May; 15(3):207-14. PubMed ID: 15187578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of PKA, MAPK/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice.
    Almeida RC; Souza DG; Soletti RC; López MG; Rodrigues AL; Gabilan NH
    Neurosci Lett; 2006 Mar; 395(2):93-7. PubMed ID: 16289784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminophylline (a theophylline-ethylenediamine complex) blocks ethanol behavioral effects in mice.
    Soares PM; Patrocínio MC; Assreuy AM; Siqueira RC; Lima NM; Arruda Mde O; de Souza Escudeiro S; de Carvalho KM; Sousa FC; Viana GS; Vasconcelos SM
    Behav Pharmacol; 2009 Jul; 20(4):297-302. PubMed ID: 19617722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.